期刊文献+

青蒿琥酯对恶性疟原虫配子体感染性影响的观察 被引量:2

INFLUENCE OF ARTESUNATE ON INFECTIVITY OF GAMETOCYTES OF PLASMODIUM FALCIPARUM
在线阅读 下载PDF
导出
摘要 越南南方疟区15例携带恶性疟原虫配子体和无性体的患者分为A、B、C 3组,A组口服青蒿琥酯片5天总量600mg,B组口服青蒿琥酯片2天总量200mg,C组静脉注射青蒿琥酯5天总量360mg。给药前、后定时血检计算配子体密度,并取血离体感染大劣按蚊。配子体转阴时间,A组为15.4±5.0天,B组为20.6±4.8天,C组为20.3±4.0天。配子体失去感染性,A组D_7(给药后7天)2/5例、D_(14)5/5例;B组D_70/5例、D_(14)1/5例、D_(21)5/5例;C组D_70/5例、D_(14)2/4例、D_(21)3/3例。研究结果表明口服青蒿琥酯5天总量600mg对清除恶性疟原虫配子体血症及抑制配子体的感染性有明显影响。 A study was carried out in south of Vietnam 15 Patients with Plasmodium falciparum gametocytes and asexual parasites were distributed into groups A, B and C. Artesunate was given orally at a total dose of 600 mg for 5 days in group A, 200 mg for 2 days in group B and intravenously at a total dose of 360 mg for 5 days in group C respectively. Gametocytes count was done before medication and daily after medication. Meanwhile, Anopheles dirus as a vector was employed to study the infectivity of gametocyte, The result showed that the mean gametocyte clearance time in three groups were respectively 15.4±5.0, 20.6±4.8 and 20.3±4.0 days. The mosquitoes were not infected from the blood in 2, 5 and 5 of 5 patients respectively on days 7, 14 and 21 in group A; 1 and 5 of 5 patients on day 14 and 21 in group B; 2 of 5 patients and 3 of 3 patients on days 14 and 21 in group C. It indicates that artesunate has remarkable effect on Plasmodium falciparum gametocytemia and its infectivity to mosquitoes.
出处 《中药新药与临床药理》 CAS CSCD 1993年第3期40-42,共3页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 青蒿琥酯片 疟疾 中医药疗法 疟原虫 配子体 ARTESUNATE/therapeutic use MALARIA/therapy, TCM ANOPHELES/microbiology
  • 相关文献

同被引文献31

  • 1陈沛泉,李国桥,郭兴伯,何坤荣,符永新,符林春,宋玉宗.青蒿素对恶性疟配子体感染性的影响[J].中华医学杂志,1994,74(4):209-210. 被引量:8
  • 2谈博,宋健平,Thou Tharith,李国桥.含与不含甲氧苄啶的两个双氢青蒿素复方治疗恶性疟的临床对照试验[J].广州中医药大学学报,2007,24(2):100-103. 被引量:3
  • 3Li GQ, Guo XB, Jin R, et al. Clinical studies on treatment of cerebral malaria witlt qinghaosu and its derivatives [J]. J Tradit Chin Med, 1982, 2(1): 125-130.
  • 4Checkley AM, Whitty CJ. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria[J].Expert Rev Anti Infect Ther, 2007, 5(2): 199-204.
  • 5Dondorp A, Nosten F, Stepniewska K, et al. Artesunate versus quinine far treatment of severe falciparum malaria : a randoraised trial [J]. Lancet, 2005, 366(9487): 717-725.
  • 6Bunnag D, Viravan C, Looareesuwan S, et al. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report [J]. Southeast Asian J Trop Med Pub Hlth, 1991, 22(3): 380-385.
  • 7Kumar N, Zheng H. Stage-specific gametocytocidal effect of the antimalarial drug qinghaosu on Plasmodiumfalciparum [ J]. Parasitol Res, 1990, 76(3): 214-218.
  • 8Li GQ, Chen PQ, Li GQN, et al. Effect of artesunate on the infectivity of Plasmodiumfalciparum gametocytes (PFG) and a randomized comparative study with quinine [ C]. XIVth International Congress for Tropical Medicine and Malaria, Nagasaki, Japan. 1996:211.
  • 9Price NR, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility[J]. Lancet, 1996, 347(9016) : 1654-1658.
  • 10Targett G, Drakcleg C, Jawara M, et al. Artesunate reduces but does not prevent post-treatment transmission of Plasmodium falciparum to Anopheles gambiae[J]. J Infect Dis, 2001, 183(8) : 1254-1259.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部